Victory Capital Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$528K Buy
31,043
+20,431
+193% +$348K ﹤0.01% 2050
2025
Q1
$207K Buy
10,612
+1,618
+18% +$31.6K ﹤0.01% 2213
2024
Q4
$223K Sell
8,994
-99
-1% -$2.46K ﹤0.01% 2207
2024
Q3
$223K Sell
9,093
-828
-8% -$20.3K ﹤0.01% 2201
2024
Q2
$232K Buy
9,921
+973
+11% +$22.8K ﹤0.01% 2164
2024
Q1
$296K Sell
8,948
-334
-4% -$11K ﹤0.01% 2123
2023
Q4
$253K Buy
+9,282
New +$253K ﹤0.01% 2174
2023
Q3
Sell
-21,483
Closed -$686K 2521
2023
Q2
$686K Sell
21,483
-151
-0.7% -$4.82K ﹤0.01% 1847
2023
Q1
$662K Buy
21,634
+1,677
+8% +$51.4K ﹤0.01% 1896
2022
Q4
$781K Sell
19,957
-1,236
-6% -$48.3K ﹤0.01% 1847
2022
Q3
$1.01M Sell
21,193
-384
-2% -$18.3K ﹤0.01% 1729
2022
Q2
$835K Sell
21,577
-663,609
-97% -$25.7M ﹤0.01% 1826
2022
Q1
$38.8M Buy
685,186
+107,516
+19% +$6.08M 0.04% 629
2021
Q4
$46M Sell
577,670
-120,209
-17% -$9.58M 0.04% 590
2021
Q3
$60.7M Buy
697,879
+163,750
+31% +$14.2M 0.06% 460
2021
Q2
$68.7M Sell
534,129
-59,476
-10% -$7.66M 0.07% 420
2021
Q1
$47.5M Buy
593,605
+515,886
+664% +$41.3M 0.05% 566
2020
Q4
$6.35M Sell
77,719
-22,022
-22% -$1.8M 0.01% 1180
2020
Q3
$2.46M Sell
99,741
-18,437
-16% -$454K ﹤0.01% 1385
2020
Q2
$3.31M Sell
118,178
-411,564
-78% -$11.5M ﹤0.01% 1276
2020
Q1
$9.54M Buy
+529,742
New +$9.54M 0.01% 1099